Skip to Main content Skip to Navigation
Journal articles

Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia

Abstract : Changes in cell metabolism and metabolic adaptation are hallmark features of many cancers, including leukemia, that support biological processes involved into tumor initiation, growth, and response to therapeutics. The discovery of mutations in key metabolic enzymes has highlighted the importance of metabolism in cancer biology and how these changes might constitute an Achilles heel for cancer treatment. In this Review, we discuss the role of metabolic and mitochondrial pathways dysregulated in acute myeloid leukemia, and the potential of therapeutic intervention targeting these metabolic dependencies on the proliferation, differentiation, stem cell function and cell survival to improve patient stratification and outcomes.
Complete list of metadatas

Cited literature [187 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02441720
Contributor : Myriam Bodescot <>
Submitted on : Thursday, January 16, 2020 - 9:55:32 AM
Last modification on : Tuesday, March 17, 2020 - 12:26:02 PM
Document(s) archivé(s) le : Friday, April 17, 2020 - 1:25:18 PM

File

s12915-019-0670-4.pdf
Publication funded by an institution

Identifiers

Collections

Citation

Lucille Stuani, Marie Sabatier, Jean-Emmanuel Sarry. Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia. BMC Biology, BioMed Central, 2019, 17 (1), pp.57. ⟨10.1186/s12915-019-0670-4⟩. ⟨inserm-02441720⟩

Share

Metrics

Record views

110

Files downloads

166